The functional significance of upregulation of CD47 by BRAF/MEK inhibitors is revealed by increased susceptibility of melanoma cells resistant to BRAF inhibitors to macrophage phagocytosis when CD47 is inhibited. Here, BRAF is linked to melanoma.